No abstract available
Keywords:
Akt; B cell receptor; chronic lymphocytic leukaemia; cytokine.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Alkylating / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
-
Apoptosis / drug effects
-
Bendamustine Hydrochloride
-
Cytokines / biosynthesis
-
Cytokines / immunology
-
Drug Synergism
-
Heterocyclic Compounds, 3-Ring / administration & dosage
-
Heterocyclic Compounds, 3-Ring / pharmacology*
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / enzymology
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Lymphocytes / drug effects
-
Lymphocytes / immunology
-
Nitrogen Mustard Compounds / administration & dosage
-
Nitrogen Mustard Compounds / pharmacology*
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
-
Proto-Oncogene Proteins c-akt / metabolism
Substances
-
Antineoplastic Agents, Alkylating
-
Cytokines
-
Heterocyclic Compounds, 3-Ring
-
MK 2206
-
Nitrogen Mustard Compounds
-
Bendamustine Hydrochloride
-
Proto-Oncogene Proteins c-akt